The spectrum of SDHD mutations in Russian patients with head and neck paraganglioma

References

• Boedeker CC. Paragangliomas and paraganglioma syndromes. GMS Curr Topics Otorhinolaryngol Head Neck Surg. 2011;10:Doc03.
   PubMedGoogle Scholar
• Werter IM, Rustemeijer C. Head and neck paragangliomas. Neth J Med. 2013;71:508–511. Epub 2014/01/08.
   PubMed Web of Science ®Google Scholar
• Jansen JC, van den Berg R, Kuiper A, et al. Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer. 2000;88:2811–2816. Epub 2000/06/28.
   PubMed Web of Science ®Google Scholar
• Sweeney AD, Carlson ML, Wanna GB, Bennett ML. Glomus tympanicum tumors. Otolaryngol Clinics North Am. 2015;48:293–304.
   PubMed Web of Science ®Google Scholar
• Fayad JN, Keles B, Brackmann DE. Jugular foramen tumors: clinical characteristics and treatment outcomes. Otol Neurotol. 2010;31:299–305.
   PubMed Web of Science ®Google Scholar
• Erickson D, Kudva YC, Ebersold MJ, Jr. et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab. 2001;86:5210–6.
   PubMed Web of Science ®Google Scholar
• Dahia PL. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer. 2014;14:108–19.
   PubMed Web of Science ®Google Scholar
• Castro-Vega LJ, Letouze E, Burnichon N, et al. Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas. Nat Commun. 2015;6:6044.
   PubMed Web of Science ®Google Scholar
• Fishbein L. Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment. Hematol/oncol Clin North Am. 2016;30:135–150.
   PubMed Web of Science ®Google Scholar
• Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346:1459–1466. Epub 2002/05/10.
   PubMed Web of Science ®Google Scholar
• Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000;287:848–851. Epub 2000/02/05.
   PubMed Web of Science ®Google Scholar
• Bayley JP, Devilee P, Taschner PE. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med Genet. 2005;6:39. Epub 2005/11/18.
   PubMed Web of Science ®Google Scholar
• Lima J, Feijao T, Ferreira da Silva A, et al. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations. J Clin Endocrinol Metab. 2007;92:4853–4864. Epub 2007/09/13.
   PubMed Web of Science ®Google Scholar
• Hensen EF, van Duinen N, Jansen JC, et al. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands. Clin Genet. 2012;81:284–288. Epub 2011/02/26.
   PubMed Web of Science ®Google Scholar
• Piccini V, Rapizzi E, Bacca A, et al. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients. Endocr Relat Cancer. 2012;19:149–155. Epub 2012/01/14.
   PubMed Web of Science ®Google Scholar
• Primer-BLAST. Bethesda (MD): National Center for Biotechnology Information. [2015]. Available from: http://www.ncbi.nlm.nih.gov/tools/primer-blast/.
   Google Scholar
• Astuti D, Hart-Holden N, Latif F, et al. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Clin Endocrinol (Oxf). 2003;59:728–733. Epub 2004/02/21.
   PubMed Web of Science ®Google Scholar
• Poeppel TD, Yuece A, Boy C, et al. Novel SDHD gene mutation (H102R) in a patient with metastatic cervical paraganglioma effectively treated by peptide receptor radionuclide therapy. J Clin Oncol. 2011;29:e812–e815. Epub 2011/10/26.
   PubMed Web of Science ®Google Scholar
• Baysal BE, Willett-Brozick JE, Lawrence EC, et al. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet. 2002;39:178–183. Epub 2002/03/19.
   PubMed Web of Science ®Google Scholar
• Baysal BE, van Schothorst EM, Farr JE, et al Repositioning the hereditary paraganglioma critical region on chromosome band 11q23. Hum Genet. 1999;104:219–225. Epub 1999/05/14.
   PubMed Web of Science ®Google Scholar
• Badenhop RF, Jansen JC, Fagan PA, et al. The prevalence of SDHB, SDHC, and SDHD mutations in patients with head and neck paraganglioma and association of mutations with clinical features. J Med Genet. 2004;41:e99. Epub 2004/07/06.
   PubMed Web of Science ®Google Scholar
• Fish JH, Klein-Weigel P, Biebl M, et al. Systematic screening and treatment evaluation of hereditary neck paragangliomas. Head Neck. 2007;29:864–873. Epub 2007/06/15.
   PubMed Web of Science ®Google Scholar
• Milunsky JM, Maher TA, Michels VV, Milunsky A. Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma. Am J Med Genet. 2001;100:311–4. Epub 2001/05/09.
   PubMed Web of Science ®Google Scholar
• Braun S, Riemann K, Kupka S, et al. Active succinate dehydrogenase (SDH) and lack of SDHD mutations in sporadic paragangliomas. Anticancer Res. 2005;25:2809–2814. Epub 2005/08/06.
   PubMed Web of Science ®Google Scholar
• Schiavi F, Dematte S, Cecchini ME, et al. The endemic paraganglioma syndrome type 1: origin, spread, and clinical expression. J Clin Endocrinol Metab. 2012;97:E637–E641.
   PubMed Web of Science ®Google Scholar
• Gimenez-Roqueplo AP, Favier J, Rustin P, et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet. 2001;69:1186–1197.
   PubMed Web of Science ®Google Scholar
• Bauters C, Vantyghem MC, Leteurtre E, et al. Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes. J Med Genet. 2003;40:e75. Epub 2003/06/17.
   PubMed Web of Science ®Google Scholar
• Aguiar RC, Cox G, Pomeroy SL, Dahia PL. Analysis of the SDHD gene, the susceptibility gene for familial paraganglioma syndrome (PGL1), in pheochromocytomas. J Clin Endocrinol Metab. 2001;86:2890–4. Epub 2001/06/09.
   PubMed Web of Science ®Google Scholar
• Dannenberg H, Dinjens WN, Abbou M, et al. Frequent germ-line succinate dehydrogenase subunit D gene mutations in patients with apparently sporadic parasympathetic paraganglioma. Clin Cancer Res. 2002;8:2061–2066. Epub 2002/07/13.
   PubMed Web of Science ®Google Scholar
• Masuoka J, Brandner S, Paulus W,et al. Germline SDHD mutation in paraganglioma of the spinal cord. Oncogene. 2001;20:5084–5086. Epub 2001/08/30.
   PubMed Web of Science ®Google Scholar
• Cascon A, Ruiz-Llorente S, Fraga MF, et al. Genetic and epigenetic profile of sporadic pheochromocytomas. J Med Genet. 2004;41:e30. Epub 2004/02/27.
   PubMed Web of Science ®Google Scholar
• Bacca A, Sellari Franceschini S, Carrara D, et al. Sporadic or familial head neck paragangliomas enrolled in a single center: clinical presentation and genotype/phenotype correlations. Head Neck. 2013;35:23–27. Epub 2012/02/01.
   PubMed Web of Science ®Google Scholar
• Antonello M, Piazza M, Menegolo M, et al. Role of the genetic study in the management of carotid body tumor in paraganglioma syndrome. Eur J Vasc Endovasc Surg. 2008;36:517–519. Epub 2008/08/12.
   PubMed Web of Science ®Google Scholar